AURINIA PHARMACEUTICALS INC (AUPH) — insider trading
Health Care · NASDAQ
AURINIA PHARMACEUTICALS INC (AUPH) has 22 reported SEC Form 4 insider transactions in our data, including 11 open-market purchases among the most recent 22 (latest 2026-06-04).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Bailey Jeffrey Allen | Director | Grant / award / vesting (derivative) | 23,931 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Nova Tina Susan | Director | Grant / award / vesting (derivative) | 23,931 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Goetz Kathleen | Director | Grant / award / vesting (derivative) | 23,931 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Johnson Craig A | Director | Grant / award / vesting (derivative) | 23,931 | $0.00 | $0 | Form 4 |
| 2026-06-02 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | Director, Officer (Chief Executive Officer), 10% owner | Other acquisition or disposition (derivative) | 10,000 | $1.65 | $16.5K | Form 4 |
| 2026-06-02 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 206,005 | $15.28 | $3.15M | Form 4 |
| 2026-06-01 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 99 | $15.34 | $1.5K | Form 4 |
| 2026-06-01 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 343,521 | $15.28 | $5.25M | Form 4 |
| 2026-05-29 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 262,682 | $15.31 | $4.02M | Form 4 |
| 2026-05-29 | TANG KEVIN; TANG CAPITAL MANAGEMENT LLC | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 2,299 | $15.35 | $35.3K | Form 4 |
| 2026-05-18 | Cole Ryan | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 70,230 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Cole Ryan | Officer (Chief Operating Officer) | Grant / award / vesting | 116,144 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Hearne Michael S | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 70,230 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Hearne Michael S | Officer (Chief Financial Officer) | Grant / award / vesting | 116,144 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Robertson Stephen P. | Officer (Chief Legal Officer) | Grant / award / vesting | 115,541 | $0.00 | $0 | Form 4 |
| 2026-03-06 | Keenan Greg | Officer (SVP, Chief Medical Officer) | Shares withheld for taxes / exercise cost | 8,069 | $14.32 | $115.5K | Form 4 |
| 2026-03-03 | TANG KEVIN | Director | Open-market purchase | 184,208 | $14.22 | $2.62M | Form 4 |
| 2026-03-02 | TANG KEVIN | Director | Open-market purchase | 115,792 | $14.21 | $1.65M | Form 4 |
| 2026-03-02 | TANG KEVIN | Director | Open-market purchase | 83,561 | $14.33 | $1.20M | Form 4 |
| 2026-02-27 | TANG KEVIN | Director | Open-market purchase | 1,600 | $14.38 | $23.0K | Form 4 |
| 2026-02-27 | TANG KEVIN | Director | Open-market purchase | 214,839 | $14.12 | $3.03M | Form 4 |
| 2026-02-27 | TANG KEVIN | Director | Open-market purchase | 300,000 | $13.90 | $4.17M | Form 4 |
Ask the chat about AUPH's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AURINIA PHARMACEUTICALS INC (AUPH).
Last updated 2026-06-04 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.